Bruce Westerman bought GlaxoSmithKline PLC ADR (NYSE: GSK)
Bruce Westerman (R-AR), a U.S. Representative, has disclosed 2 trades in GlaxoSmithKline PLC ADR (GSK) since 2025, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Bruce Westerman bought $1,001 - $15,000 of GlaxoSmithKline PLC ADR (NYSE: GSK) on March 3, 2025. Since that trade, GSK is up +47.17% against the S&P 500 up +26.77%, an outperformance of +20.40%.
Across these filings, Bruce Westerman has been a balanced trader of GSK (a buy-to-sell ratio of 1.00). The most recent disclosed GSK transaction shown was dated April 21, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Bruce Westerman's GSK trades vs the price
GSK is up +47.17% since Bruce Westerman bought on March 3, 2025, versus +26.77% for the S&P 500.
Performance since this trade
All Bruce Westerman GSK trades
Bruce Westerman & GSK trading FAQ
Is it legal for Bruce Westerman to trade GlaxoSmithKline PLC ADR (GSK) stock?
Yes. Members of Congress are allowed to trade individual stocks, including GlaxoSmithKline PLC ADR (GSK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Bruce Westerman buy GSK?
Bruce Westerman disclosed a purchase of $1,001 - $15,000 of GlaxoSmithKline PLC ADR (GSK) on March 3, 2025, according to public STOCK Act filings.
How has GSK performed since Bruce Westerman's trade?
Since Bruce Westerman bought GSK on March 3, 2025, the stock is up +47.17%, versus +26.77% for the S&P 500 over the same period, an outperformance of +20.40%.
How many times has Bruce Westerman traded GSK?
Bruce Westerman has disclosed 2 GSK trades since 2025 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GSK trades?
Quantellect tracks every disclosed congressional trade in GlaxoSmithKline PLC ADR (GSK) on the GlaxoSmithKline PLC ADR congressional trading page, which aggregates filings across all members of Congress.
Bruce Westerman's GSK tradesAll congressional filings for GlaxoSmithKline PLC ADRBruce Westerman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.